December 31, 2008

Two Agree on 3SBIO

3SBIO (SSRX) is a Chineese BioTech company that has been pegged as undervalued and in store for high growth. In this article, the Fool has dubbed shares of the company cheap, especially compared to other stocks in the industry.

In this article, Zacks also likes the growth prospects of the company and have given a price target of $10 over the next 6 to 12 months.

No comments: